Skip to main content
OpenTrials
Completed

NCT Number: NCT02176889

A Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals

The purpose of this study is to determine whether Lactospore is safe in healthy adults.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

KGK Synergize Inc.

London, Ontario, N6A 5R8, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female ≥18 years of age
  • If female, subject is not of child bearing potential or female subject of childbearing potential must agree to use a medically approved method of birth control and have a negative urine pregnancy test result.
  • Healthy as determined by laboratory results and medical history
  • Normal BMI 18.5 - 29.9 kg/m2
  • Has given voluntary, written, informed consent to participate in the study

Exclusion criteria

  • Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial
  • Subject has any clinically significant medical conditions
  • Subject requires the use of prescribed medications (other than birth control)
  • Use of illicit drugs or history of drug or alcohol abuse with the past 5 years (currently having more than 2 standard alcoholic drinks per day)
  • Participation in a clinical research trial within 30 days prior to randomization
  • Clinically significant abnormal laboratory results at screening
  • Allergy or sensitivity to test product ingredients
  • Individuals who are cognitively impaired and/or who are unable to give informed consent
  • Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject

Treatment and study plan

Lactospore

Dietary Supplement

Bacillus coagulans MTCC 5856

Placebo

Other

Primary outcomes

  1. Safety and Tolerability: Lab parameters

    Time frame: Over 30 days

    CBC, electrolytes (Na, K, Cl), glucose, creatinine, AST, ALT, GGT, and bilirubin levels

  2. Safety and Tolerability: Anthropometric safety measures

    Time frame: Over 30 days

    Blood pressure, Heart Rate, Weight, BMI

  3. Safety and Tolerability: Number of Adverse Events

    Time frame: Over 30 days

Sponsors and collaborators

Lead sponsor

KGK Science Inc.

Industry

Collaborators

  • Sabinsa Corporation

Registry information

Official study title

A Double-blind, Placebo-controlled, Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals

Acronym: 14PSHS

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Jun 27, 2014
Registry last updated
Sep 9, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.